USANA Health Sciences (NYSE:USNA) Director John Turman Fleming Sells 1,750 Shares

USANA Health Sciences, Inc. (NYSE:USNA) Director John Turman Fleming sold 1,750 shares of the company’s stock in a transaction dated Friday, October 31st. The shares were sold at an average price of $19.79, for a total transaction of $34,632.50. Following the sale, the director owned 4,565 shares of the company’s stock, valued at approximately $90,341.35. The trade was a 27.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

USANA Health Sciences Stock Up 0.8%

NYSE USNA opened at $21.32 on Tuesday. The company has a 50-day simple moving average of $26.57 and a two-hundred day simple moving average of $28.82. USANA Health Sciences, Inc. has a 12-month low of $18.69 and a 12-month high of $41.83. The firm has a market cap of $389.56 million, a price-to-earnings ratio of 24.23, a PEG ratio of 0.94 and a beta of 0.61.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Thursday, October 9th. The company reported $0.56 earnings per share (EPS) for the quarter. The business had revenue of $200.22 million during the quarter. USANA Health Sciences had a net margin of 1.86% and a return on equity of 6.96%. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. Equities analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Institutional Trading of USANA Health Sciences

Several institutional investors and hedge funds have recently bought and sold shares of the stock. US Bancorp DE lifted its holdings in USANA Health Sciences by 13.1% in the first quarter. US Bancorp DE now owns 4,611 shares of the company’s stock worth $124,000 after buying an additional 535 shares during the period. Creative Planning increased its stake in shares of USANA Health Sciences by 3.2% during the second quarter. Creative Planning now owns 20,051 shares of the company’s stock valued at $612,000 after purchasing an additional 613 shares in the last quarter. Quantbot Technologies LP increased its stake in shares of USANA Health Sciences by 19.5% during the second quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock valued at $121,000 after purchasing an additional 646 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in shares of USANA Health Sciences by 339.6% during the first quarter. PNC Financial Services Group Inc. now owns 998 shares of the company’s stock valued at $27,000 after purchasing an additional 771 shares in the last quarter. Finally, Martingale Asset Management L P increased its stake in shares of USANA Health Sciences by 5.4% during the first quarter. Martingale Asset Management L P now owns 17,542 shares of the company’s stock valued at $473,000 after purchasing an additional 900 shares in the last quarter. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on USNA. Zacks Research lowered shares of USANA Health Sciences from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 21st. Wall Street Zen lowered shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of USANA Health Sciences in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and an average target price of $36.00.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.